Comparative efficacy of palbociclib, ribociclib and abemaciclib for ER+ metastatic breast cancer: an adjusted indirect analysis of randomized controlled trials

Overview of attention for article published in Breast Cancer Research and Treatment, January 2019

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
Good Attention Score compared to outputs of the same age and source (72nd percentile)

So far, Dimensions has found 56 publications that cite this research output.

Article in Expert Opinion on Drug Safety (March 2024)

Article in Cancer Chemotherapy and Pharmacology (March 2024)

Article in Frontiers in Pharmacology (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.